Tag archive for ‘The Rohatyn Group’
By pharmanewsdaily On Wednesday, May 13th, 2020
0 Comments

Rohatyn Group completes investment in Croatian CRO Optimapharm

The Rohatyn Group (TRG), a US asset management firm focusing on emerging markets, has completed an investment in Optimapharm, a contract research organization (CRO) based in Croatia. The Croatian CRO, which was More...